Article: Endovasc Ltd., Inc. v. J. P. Turner Co., LLC

Article - Media, Publications
12875

Endovasc Ltd., Inc. v. J. P. Turner Co., LLC

OffshoreAlert, 11 September 2002

Plaintiff, Endovasc Ltd., Inc. (“Endovasc” or “Plaintiff”, brings this action asserting in their Second Amended Complaint (the “Complaint” or “Compl.”) that they were injured by the fraudulent acts of defendants J.P. Turner Co., LLC (“JP Turner”), KCM Group LLC (“KCM”), The Keshet Fund, L.P. “Keshet Fund”), Keshet, LP (“Keshet”), Nesher, Ltd. (“Nesher”), Talbiya B. Investments, Ltd. (“Talbiya”), Balmore Funds S.A. (“Balmore”), David Grin (“Grin”), LH Financial Services Corp. “LH”), Laurus Master Fund, Ltd. (“Laurus Master Fund”), Laurus Capital Management, LLC (“Laurus Capital”), Celeste Trust Reg.”Celeste’, Patrick Power; “Power”), and John Clark (“Clark”) (collectively, “Defendants”), in violation of Section 10(b) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b) (“Section 10(b)”) and Rule 10b-5 promulgated thereunder by the Securities and Exchange Commission (“SEC”), 17 C.F.R. § 240.10b-5 (“Rule 10b-5”) and Section 20(a) of the Securities Exchange Act (“Section 20(a)”), 15 U.S.C. § 78t(a).

Endovasc also asserts claims for common law fraud and deceit, civil conspiracy to defraud, breach of contract, and restitution under the Securities Exchange Act of 1934. Defendants move to dismiss the Complaint in its entirety on various grounds and for sanctions under Rule 11 of the Federal Rules of Civil Procedure. For the reasons stated below, Defendants’ motions to dismiss are granted, and their motions for sanctions denied.

Read Full Article

12875